TBX2 protein acts as a switch to drive prostate cancer treatment resistance, study finds

According to the American Cancer Society, approximately 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime. In addition, about 1 in 44 men will die from the disease, placing it second behind lung cancer as the leading cause of cancer death among American males.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup